Global Urinalysis Market Overview
The key driver impacting the urinalysis market is the growing global prevalence of kidney diseases and urinary tract infections. For instance, as per WHO report, in 2015, there were 1.2 million people died from kidney failure, an increase of 32% since 2005. Around 2.3 to 7.1 million people died due to end-stage kidney disease with no access to chronic dialysis in the year 2010. Also, every year, about 1.7 million people are thought to die from acute kidney injury. It is expected that 5to10 million people die yearly from kidney disease. As per the national kidney foundation, In the U.S., kidney disease is the 8th leading cause of death in 2019. In 2018, there were over 500,000 patients received dialysis treatment, and around 200,000 lived with a kidney transplant. It is estimated that In the U.S., kidney disease affects about 37 million people. Moreover, the development of technologically advanced diagnostics and CLIA waived tests contributes to the urinalysis market's growth in the coming years.
According to Value Market Research, the global urinalysis market size was valued at around USD 3,250 million in 2020 and is estimated to grow at a CAGR of about 7.5% during the forecast period 2021 to 2027.
The growing base of the geriatric population globally is estimated to augment urinalysis needs in the forecast period. For instance, Asper the United Nations report estimations, In 2020, around 727 million persons aged 65 years or over globally. This number is estimated to get double by 2050, reaching over 1.5 billion persons. The share of older persons in the global population is expected to increase from 9.3% in 2020 to 16.0% in 2050. Chronic kidney disease is a major risk multiplier in patients with hypertension, diabetes, heart disease, and stroke-all, which are key reasons for death and disability in older adults. However, the Lack of healthcare infrastructure may hamper the market in the long run. Also, the presence of an ambiguous regulatory framework negatively impacts the market. The current industry trends, such as the Integrated Systems for Urinalysis and high unmet clinical wants in the under-developed regions, are expected to offer new market opportunities for the key players.
The urinalysis market is vast, with many local and global players. The urinalysis market is extensive, with many international and regional players. The key market leaders follow several strategies to improve their market statuses, such as extending product portfolio, amalgamation, contracts, acquisitions, product upgrades to enlarge their market share across the globe. The important players studied in the report are ARKRAY, Inc., Alere, Inc., Mindray, Bio-Rad, Siemens Healthcare, Roche Diagnostics, and Sysmex.
In this research report, the urinalysis market is segmented by product, application, end-user, and region.
Analysis by Product
By product, the report is categorized into consumables and instruments. Consumables dominate the product segment with over 55% share in 2020. It is further segmented into pregnancy & fertility kits, dipsticks, reagents, and disposables. There is massive adoption of kits amongst end-users globally due to their cost-effectiveness and ease of use. Moreover, the growing need for rapid pregnancy testing and extensive usage of urine collection cups thus contributes to the growth of the consumables product segment in the forecast period.
Analysis by Application:
By application, the report is categorized into UTIs, diabetes, kidney disease, hypertension, liver disease, and others. UTIs are expected to show considerable growth in the forecast period. It is due to the growing prevalence of target diseases, such as kidney diseases, diabetes, and Urinary Tract Infections (UTI), and the introduction of technologically advanced, rapid, non-invasive, and user-friendly tools for urinalysis. Moreover, the high prevalence of hospital-acquired urinary tract infections, particularly in females, and effective diagnosis by urinalysis contribute to the increased market demand in the forecast period.
Analysis by End-User:
By end-use, the report is categorized into clinical laboratories, hospitals, research, home healthcare, and academics. The clinical laboratories segment dominates the end-user segment with a 40% share in 2020. It is due to the growing trend of automation being used in urine analysis diagnostics. Moreover, the high procedure volumes associated with these establishments contribute to the segment's growth in the forecast period.
Analysis by Region:
In the regional outlook of the global Urinalysis market, the North America region dominates globally with a 25% market share in the forecast period. It is due to the introduction of automated urine sediment analyzers such as digital flow morphology (digital imaging) & fluorescence flow cytometry coupled with high healthcare expenditure. Moreover, the presence of key players in the region, such as Alere, Inc., Siemens Healthcare, Bio-Rad, and Beckman Coulter, contributes to market growth across North America.
Market Segmentation covered in the Report:
By Product
- Instruments (Biochemical urine analyzers (Automated biochemical analyzers, Semi-automated biochemical analyzers), Automated urine sediment analyzers (Microscopic urine analyzers, Flow-cytometric urine analyzers)
- Consumables (Dipsticks, Reagents, Disposables)
By Application
- UTIs
- Diabetes
- Kidney Disease
- Hypertension
- Liver disease
- Others
By End-User
- Hospitals
- Clinical Laboratories
- Home healthcare
- Research and academics
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.